About
Joel S. Schuman
Joel S. Schuman, M.D. is a native of Roslyn, NY; he graduated Columbia University (AB, 1980) and Mt. Sinai School of Medicine (MD, 1984). Following internship at New York’s Beth Israel Medical Center (1985), he completed residency training at Medical College of Virginia (1988) and glaucoma fellowship at Massachusetts Eye & Ear Infirmary (clinical 1989, research 1990), where he was a Heed fellow. After just over a year on the Harvard faculty, he moved to New England Medical Center, Tufts University to co-found New England Eye Center in 1991, where he was Residency Director and Glaucoma and Cataract Service Chief. In 1998 he became Professor of Ophthalmology, and Vice Chair in 2001.
Dr. Schuman, is the Eye and Ear Foundation Professor and Chairman of Ophthalmology, the Eye and Ear Institute, University of Pittsburgh School of Medicine and Director of the University of Pittsburgh Medical Center (UPMC) Eye Center. He is also Professor of Bioengineering at the Swanson School of Engineering, University of Pittsburgh, and Professor in the Center for the Neural Basis of Cognition, Carnegie Mellon University and University of Pittsburgh and a member of the McGowan Institute for Regenerative Medicine. Dr. Schuman and his colleagues were the first to identify a molecular marker for human glaucoma, as published in Nature Medicine in 2001. He has been continuously funded by the National Eye Institute as a principal investigator since 1995, is principal investigator of a National Institutes of Health (NIH) grant to study novel glaucoma diagnostics, and is co-investigator of NIH grants for research into novel optical diagnostics and short pulse laser surgery and for advanced imaging in glaucoma. He is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 200 peer-reviewed scientific journal articles, has authored or edited 8 books, and has contributed more than 50 book chapters.
Dr. Schuman is a founding member of the ARVO Multidisciplinary Ophthalmic Imaging cross-sectional group, served on the program committee from its founding and chairs the MOI program committee 2007-2008. He is also a founder and chair of ARVO/isie (The International Society for Imaging in the Eye, inaugurated 2002). Dr. Schuman was co-chair of the International Glaucoma Symposium 1998-2007, the world’s largest meeting devoted to glaucoma, which merged with the World Glaucoma Congress in 2007, for which he is Program co-Chair 2007-2011. With the exception of a three year hiatus, he has chaired the Hawaiian Eye meeting glaucoma section since 1993.
